ERBB2 and breast carcinoma: Several of them (CHD3, SP1, PALB2, ERBB2, USP28, KLHL4, CDC6, KIAA1468, RNF220, COL1A1 and SNX4) had been previously identified as mutated in breast cancer but at different positions [11].